SK Biopharmaceuticals launches epilepsy drug in France

SK Biopharm's Cenobamate South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company launched the same drug in 15 European countries, beginning with Germany in June this year. The local drug brand name is "On